Bello-Manabat Dalesay C & Manabat Gregorio Pontiac, IL - 61764

Bello-Manabat Dalesay C & Manabat Gregorio is categorized under Doctors in Pontiac, IL and active since 1977.

Bello-Manabat Dalesay C & Manabat Gregorio was established in 1977, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Gregorio Manabat at the company’s single location by writing to 1504 West Reynolds St # C, Pontiac, Illinois IL 61764 or by phoning (815) 842-2893. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bello-Manabat Dalesay C & Manabat Gregorio
Contact Person: Gregorio Manabat
Address: 1504 West Reynolds St # C, Pontiac, Illinois 61764
Phone Number: (815) 842-2893
Annual Revenue (USD): $100.000 to $499.999
Founded: 1977
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Bello-Manabat Dalesay C & Manabat Gregorio was started in 1977 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Gregorio Manabat for inquiries that concern Bello-Manabat Dalesay C & Manabat Gregorio by calling the company number (815) 842-2893, as your correspondence is most welcome. Additionally, the physical location of the single location of Bello-Manabat Dalesay C & Manabat Gregorio can be found at the coordinates as well as the street address 1504 West Reynolds St # C in Pontiac, Illinois 61764.

For its online presence, you may visit Bello-Manabat Dalesay C & Manabat Gregorio’s website at and engage with its social media outlets through on Twitter and on Facebook.